Related Experiment Video
Updated: Dec 2, 2025
08:16
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
Published on: March 15, 2024
1.9K
New and Emerging Technologies in Type 1 Diabetes.
Jordan S Sherwood1, Steven J Russell1, Melissa S Putman1
1Diabetes Research Center, Massachusetts General Hospital, 50 Staniford Street, Suite 301, Boston, MA 02114, USA.
Endocrinology and Metabolism Clinics of North America
|November 6, 2020
Summary
New diabetes technologies and therapies improve type 1 diabetes management. Advances include insulin analogues, pumps, continuous glucose monitoring, and automated insulin delivery systems for better glycemic control.
Area of Science:
- Endocrinology
- Biomedical Engineering
- Diabetes Technology
Background:
- The Diabetes Control and Complications Trial demonstrated that intensive insulin therapy and tight glycemic control reduce diabetes complications.
- Technological advancements aim to assist patients in achieving target glycemic control for type 1 diabetes management.
Purpose of the Study:
- To review recent advancements in diabetes therapeutics and technologies for type 1 diabetes.
- To highlight innovations that support improved glycemic control and complication reduction.
Main Methods:
- Review of current literature on novel diabetes management strategies.
- Discussion of emerging technologies in insulin therapy and glucose monitoring.
Main Results:
- Significant progress in developing new insulin analogues with improved pharmacokinetic profiles.
- Introduction of advanced insulin pumps, continuous glucose monitoring (CGM) systems, and automated insulin delivery (AID) systems.
- These technologies facilitate more precise glucose monitoring and insulin administration.
Conclusions:
- The reviewed therapeutics and technologies offer promising avenues for enhancing type 1 diabetes management.
- Continued innovation in diabetes technology is crucial for improving patient outcomes and reducing long-term complications.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
4.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.5K
01:22Diabetes Mellitus: Type 2 and Gestational
4.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.0K
01:15Diabetes: Management and Pharmacotherapy
744
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
744
01:29Issues And Trends In Healthcare Delivery System
6.0K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K
01:15Diabetes: Symptoms, Diagnosis, and Complications
1.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.7K
01:16Insulin: Dosing Regimen and Adverse Effects
491
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
491